首页 | 本学科首页   官方微博 | 高级检索  
     

IL-28B基因多态性对干扰素治疗丙型病毒性肝炎应答的影响
引用本文:佟小非,尤红. IL-28B基因多态性对干扰素治疗丙型病毒性肝炎应答的影响[J]. 首都医科大学学报, 2012, 33(3): 334-337. DOI: 10.3969/j.issn.1006-7795.2012.03.011
作者姓名:佟小非  尤红
作者单位:首都医科大学附属北京友谊医院肝病中心,北京 100050
摘    要:目前针对丙型肝炎的标准治疗方案是聚乙二醇干扰素联合利巴韦林。宿主IL-28B基因多态性对丙型病毒性肝炎干扰素治疗清除有影响,可以对治疗应答进行预测。本文将从IL-28B基因多态性与慢性丙型肝炎治疗应答的关系及其影响应答的可能机制两个方面,对宿主IL-28B基因在慢性丙型肝炎治疗实践中的意义进行探讨。

关 键 词:丙型病毒性肝炎  全基因组关联分析  白细胞介素28B  干扰素-λ  干扰素-α
收稿时间:2012-02-14

Genetic polymorphisms of interleukin 28-B play an important role in response to treatment of chronic hepatitis C
TONG Xiao-fei,YOU Hong. Genetic polymorphisms of interleukin 28-B play an important role in response to treatment of chronic hepatitis C[J]. Journal of Capital Medical University, 2012, 33(3): 334-337. DOI: 10.3969/j.issn.1006-7795.2012.03.011
Authors:TONG Xiao-fei  YOU Hong
Affiliation:Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
Abstract:The current standard of care for chronic infection with hepatitis C virus is pegylated interferon-alfa(PEG-IFN) and ribavirin (RBV).Genetic variation in interleukin 28-B ( IL-28B ) play an important role in treatment response of chronic hepatitis C. It may be a strong predictor for the therapy of interferon. This paper discusses the significance of IL-28B in the therapy of chronic hepatitis C through the relationship between IL-28B and treatment response with its possible mechanism.
Keywords:hepatitis C  genome-wide association study  interleukin 28-B  interferon-λ  interferon-α
点击此处可从《首都医科大学学报》浏览原始摘要信息
点击此处可从《首都医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号